Sarcosine as Primary or Adjunctive Therapy in Obsessive Compulsive Disorder: A Prospective, Open-label Study
This clinical trial evaluated the efficacy and safety of N-methyl glycine (sarcosine) as a treatment for OCD. Conducted by China Medical University Hospital, the study involved 30 participants over a 10-week period, focusing on the drug's potential to modulate glutamatergic dysfunction associated with OCD.
Indication: Obsessive Compulsive Disorder
Modality: small molecule
Target: Obsessive Compulsive Disorder (OCD)
Sponsor: China Medical University Hospital
Source URL: ClinicalTrials.gov
Source updated: Dec 29, 2009
Ingested: May 23, 2026
Model: trialsignal-ai-v1
Validation: validated
Matched by target_normalized: Obsessive Compulsive Disorder (OCD)
View original source fields
Condition raw: Obsessive Compulsive Disorder
Condition normalized: Obsessive Compulsive Disorder
Modality raw: Obsessive Compulsive Disorder
Modality normalized: small molecule
Target raw: Obsessive Compulsive Disorder (OCD)
Target normalized: Obsessive Compulsive Disorder (OCD)